-Reuters
Wells Fargo Maintains Equal-Weight on Pulmonx, Lowers Price Target to $6
Wells Fargo analyst Larry Biegelsen maintains Pulmonx (NASDAQ:LUNG) with a Equal-Weight and lowers the price target from $13.5 to $6.
Related Posts
This Crazy Galaxy S23 Ultra Deal Gets You A Free Samsung TV And Up To $1,000 Off
The Samsung Galaxy S23 Ultra is now available with a $1,000 trade-in rebate and free Samsung TV offer on Verizon.
On December 29, Phoenix Motor Inc Entered Into Several Agreements With Its Vendors To Settle Performance And Payment Obligations
- SEC FilingOn December 29, 2023, Phoenix Motor Inc. ("Phoenix" or the "Company") entered into several agreements with its vendors to settle performance and payment obligations.IAT AgreementsThe Company, and its
$1000 Invested In This Stock 5 Years Ago Would Be Worth $3,400 Today
Seagen (NASDAQ:SGEN) has outperformed the market over the past 5 years by 18.41% on an annualized basis producing an average annual return of 27.81%. Currently, Seagen has a market capitalization of $32.98 billion.